Wet Age-related Macular Degeneration

• CLINICAL_TRIALS trial_result · 2012-01-19
  Clinical Trial Update: Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) [Phase 1]

  This Phase 1 trial update reports on the safety and tolerability of the IRay System in subjects with exudative choroidal neovascularization …

• CLINICAL_TRIALS trial_result · 2011-07-27
  Clinical Trial Update: A Study to Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF Therapy [Phase 2]

  A Phase 2 trial evaluating the Neovista Ophthalmic System for treating subfoveal CNV in wet age-related macular degeneration patients who fa…

• CLINICAL_TRIALS trial_result · 2011-07-22
  Clinical Trial Update: A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD [Phase 3]

  Phase 3 study evaluating how genetic and environmental factors affect response to Lucentis in wet age-related macular degeneration. The tria…

• CLINICAL_TRIALS trial_result · 2011-05-04
  Clinical Trial Update: Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration [Phase 2]

  Pfizer-sponsored Phase 2 trial of pegaptanib sodium (Macugen) for wet age-related macular degeneration has completed, with results posted in…

• CLINICAL_TRIALS trial_result · 2010-11-23
  Clinical Trial Update: Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD) [Phase 2]

  A Phase 2 trial update for ATG003 in wet age-related macular degeneration reports safety and efficacy findings; the study was terminated and…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2008-11-14
  Clinical Trial Update: Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD) [Phase 1, Phase 2]

  Phase 1/2 clinical trial evaluating the safety and efficacy of oral PTK787 (Vatalanib) in patients with subfoveal choroidal neovascularizati…

• CLINICAL_TRIALS trial_result · 2008-08-05
  Clinical Trial Update: Safety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration [Phase 2]

  A Phase 2 trial evaluating the safety and efficacy of the Cand5 RNA molecule for wet age-related macular degeneration has completed.

• CLINICAL_TRIALS trial_result · 2008-01-09
  Clinical Trial Update: MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD) [Phase 2]

  Phase 2 trial of MSI-1256F (squalamine lactate) in combination with verteporfin for wet age-related macular degeneration was terminated. Thi…

• CLINICAL_TRIALS trial_result · 2007-12-28
  Clinical Trial Update: Safety and Tolerability of an Intravenous Infusion of ACZ885 in Patients With Wet Age-Related Macular Degeneration [Phase 1]

  Phase 1 safety and tolerability study of intravenous ACZ885 (canakinumab) in patients with wet age-related macular degeneration.

• CLINICAL_TRIALS trial_result · 2007-01-15
  Clinical Trial Update: A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD) [Phase 4]

  A Phase 4 trial evaluating three doses of pegaptanib sodium for wet age-related macular degeneration was terminated.